Abstract:B lymphocyte stimulator (BLyS) is a member of the tumor necrosis factor (TNF) ligand superfamily that functionally involved in B cell proliferation. Here, the full length cDNA of human soluble BlyS (hsBLyS) was amplified by reverse transcription-PCR from total RNA of human peripheral blood lymphocytes and sequenced. The cloned cDNA fragments was inserted into pBV220, a thermo-sensitive expression plasmid, forming recombinant plasmid pBV220/hsBLyS. The two mutants of hsBLyS: hsBY-A (Cys(146) right curved arrow Ala(146), TGC right curved arrow GCT) and hsBY-V (Cys(146) right curved arrow Val(146), TGC right curved arrow GTT), were amplified by overlap PCR from pBV220/hsBLyS and inserted into the pBV220 to form pBV220/hsBY-A and pBV220/hsBY-V expression plasmids as the method above. The three expression plasmids were transformed into E.coli DH5alpha and it was found that the recombinant proteins were highly expressed as inclusion bodies. Pure recombinant proteins were obtained by Sephacryl-200 gel filtration and renaturation. The experimental results demonstrated that the sequences of the PCR products were identical with the published hsBLyS cDNA sequence or expected mutant sequence and the purity of the recombinant proteins obtained was relatively high. The activity of the purified recombinant proteins was very significant in the B cell survival and proliferation assay, and statistical tests indicated that the mutant rhsBY-V promoted proliferation of B lymphocyte cell remarkably better than the wild type.

Production and Purification of Recombinant Human BLyS Mutant from Inclusion Bodies.

Preparation and Characterization of a Monoclonal Antibody Against Human B Lymphocyte Stimulator

[Study on Optimization of Expression, Purification, Properties and Biological Function of Recombinant Human Sblys].

Cloning, Expression, and Purification of the Immune Inhibitor of Human BLyS

Construction and direct immunization of eukaryotic expression plasmid encoding human soluble B lymphocyte stimulator.

Expression and purification and functional analysis of human BLyS

[Clonging, Expression and Activity Determination of the Recombinant Human Soluble B Lymphocyte Stimulator and Its Two Mutants].

Cloning, Expression, Purification and Activity of the Hsblys.

Generation of a fusion protein of the extracellular domain of BR3 with the Fc fragment of human IgG1 (sBR3-Fc) in Pichia pastoris as an antagonist for BLyS

The pharmaceutical prospect of B lymphocyte stimulator

Expression and Purification of Soluble B Lymphocyte Stimulator from Recombinant Escherichia Coli

Primary Immune Effects of Eukaryotic Expression Plasmids Encoding Two Hyperactive Mutants of Human Soluble B Lymphocyte Stimulator

[Cloning and Expression of Soluble B Lymphocyte Stimulator].

Construction and Function of Two Cys146-mutants with High Activity, Derived from Recombinant Human Soluble B Lymphocyte Stimulator.

Two Observed Regions in B Lymphocyte Stimulator Important for Its Biological Activity

The Construction of Human B Lymphocyte Stimulator-Transfected Cells and Effects of Its Signal on B Lymphocytes

Expression, purification, and characterization of recombinant human soluble BAFF secreted from the yeast Pichia pastoris

A Novel BLyS Antagonist Peptide Designed Based on the 3-D Complex Structure of BCMA and BLyS

An Optimized B Lymphocyte Stimulator (blys) Antagonist Peptide Inhibits the Interaction of BLyS with BCMA

Amelioration of experimental autoimmune encephalomyelitis by BLyS autovaccine.

Development and functional identification of an anti-rhBlyS chimeric antibody